Melatonin

被引:333
作者
Hardeland, R
Pandi-Perumal, SR
Cardinali, DP
机构
[1] Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany
[2] CUNY Mt Sinai Sch Med, Dept Pulm Crit Care & Sleep Med, Comprehens Ctr Sleep Med, New York, NY 10029 USA
[3] Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina
关键词
kynuramines; melatonin; mitochondria; radicals;
D O I
10.1016/j.biocel.2005.08.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Melatonin, originally discovered as a hormone of the pineal gland, is produced by bacteria, protozoa, plants, fungi, invertebrates, and various extrapineal sites of vertebrates, including out, skin, Harderian gland, and leukocytes. Biosynthetic pathways seem to be identical. Actions are pleiotropic, mediated by membrane and nuclear receptors, other binding sites or chemical interactions. Melatonin regulates the sleep/wake cycle, other circadian and seasonal rhythms, and acts as an immunostimulator and cytoprotective agent. Circulating melatonin is mostly 6-hydroxylated by hepatic P-450 monooxygenases and excreted as 6-sulfatoxymelatonin. Pyrrole-ring cleavage is of higher importance in other tissues, especially the brain. The product, N-1-acetyl-N-2-formyl-5-methoxykynuramine, is formed by enzymatic, pseudoenzymatic, photocatalytic, and numerous free-radical reactions. Additional metabolites result from hydroxylation and nitrosation. The secondary metabolite, N-1-acetyl-5-methoxykynuramine, supports mitochondrial function and downregulates cyclooxygenase 2. Antioxidative protection, safeguarding of mitochondrial electron flux, and in particular, neuroprotection, have been demonstrated in many experimental systems. Findings are encouraging to use melatonin as a sleep promoter and in preventing progression of neurodegenerative diseases. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:313 / 316
页数:4
相关论文
共 19 条
  • [1] Blask David E., 2002, Current Topics in Medicinal Chemistry, V2, P113, DOI 10.2174/1568026023394407
  • [2] Carlberg C, 2000, ANN NY ACAD SCI, V917, P387
  • [3] Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan:: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase
    Ferry, G
    Ubeaud, C
    Lambert, PH
    Bertin, S
    Cogé, F
    Chomarat, P
    Delagrange, P
    Serkiz, B
    Bouchet, JP
    Truscottj, RJW
    Boutin, JA
    [J]. BIOCHEMICAL JOURNAL, 2005, 388 (01) : 205 - 215
  • [4] Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis
    Ganguly, S
    Gastel, JA
    Weller, JL
    Schwartz, C
    Jaffe, H
    Namboodiri, MAA
    Coon, SL
    Hickman, AB
    Rollag, M
    Obsil, T
    Beauverger, P
    Ferry, G
    Boutin, JA
    Klein, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) : 8083 - 8088
  • [5] Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335
  • [6] Non-vertebrate melatonin
    Hardeland, R
    Poeggeler, B
    [J]. JOURNAL OF PINEAL RESEARCH, 2003, 34 (04) : 233 - 241
  • [7] Antioxidative protection by melatonin - Multiplicity of mechanisms from radical detoxification to radical avoidance
    Hardeland, R
    [J]. ENDOCRINE, 2005, 27 (02) : 119 - 130
  • [8] Hardeland Ruediger, 1996, P25
  • [9] HIRATA F, 1974, J BIOL CHEM, V249, P1311
  • [10] Targeted disruption of the mouse Mel1b melatonin receptor
    Jin, XW
    von Gall, C
    Pieschl, RL
    Gribkoff, VK
    Stehle, JH
    Reppert, SM
    Weaver, DR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (03) : 1054 - 1060